The DOI matches its Crossref record; 155 of the 158 references it cites were found in a registry or an index.
Anemia of Chronic Disease
Abstract
New therapeutic strategies have emerged along with our understanding that disturbances of iron homeostasis, impaired proliferation of erythroid progenitor cells, and blunted erythropoietin response occur in anemia of chronic disease. This review discusses advances in our knowledge of the causes and management of the condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the underlying disease, ACD occurs in up to 95% of individuals affected by inflammatory or infectious diseases (Weiss and Goodnough, 2005).”
From Iron in infection and immunity (2020) · cites this paper as Weiss and Goodnough, 2005
In the citing paper
“ACD is considered to be the second most frequent anemia worldwide and it develops specifically in patients suffering from chronic inflammatory diseases, such as auto-immune disorders, cancer, chronic infections or in patients undergoing dialysis (Weiss and Goodnough, 2005).”
From Iron at the interface of immunity and infection (2014) · cites this paper as Weiss and Goodnough, 2005
In the citing paper
“Thereby, cytokines and acute-phase proteins affect body iron homeostasis and macrophage iron metabolism leading to an inflammation driven diversion of iron traffic which is characterized by low circulating iron concentrations and high levels of the iron storage protein ferritin , the latter reflecting iron retention in the MPS (Thomas and Thomas, 2005; Weiss and Goodnough, 2005).”
From Iron at the interface of immunity and infection (2014) · cites this paper as Weiss and Goodnough, 2005
In the citing paper
“Proinflammatory cytokines such as IL-6 and IL-1β, produced in chronic infections, autoimmunity, cancer, renal failure and other chronic disorders activate hepcidin expression leading to iron-restricted erythropoiesis and anemia of inflammation, once named anemia of chronic diseases.84,97,98”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [98]
In the citing paper
“However, targeting the hepcidin-ferroportin axis may not fully correct this multifactorial anemia characterized by low erythropoietin and a blunted erythropoietic response.97,98”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [98]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Anemia and Blood Transfusion in Critically Ill Patients
Vincent, J. L. (2002) · JAMA · doi:10.1001/jama.288.12.1499 · Cited by 1,821
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2865 · Cited by 974
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
A Clinical Evaluation of Serum Ferritin as an Index of Iron Stores
Lipschitz, D. A., Cook, J. D., & Finch, C. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197405302902201 · Cited by 938
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
Groopman, J. E., & Itri, L. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1616 · Cited by 929
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Serum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency
Punnonen, K., Irjala, K., & Rajamäki, A. (1997) · Blood · doi:10.1182/blood.v89.3.1052 · Cited by 859
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2003) · Blood · doi:10.1182/blood-2003-01-0223 · Cited by 845
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D., & Spivak, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222401 · Cited by 658
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
Jiang, R. (2004) · JAMA · doi:10.1001/jama.291.6.711 · Cited by 598
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 597
Hematocrit Level and Associated Mortality in Hemodialysis Patients
MA, J. Z., EBBEN, J., XIA, H., & COLLINS, A. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103610 · Cited by 577
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567
Iron Deficiency and Erythropoiesis: New Diagnostic Approaches
Brugnara, C. (2003) · Clinical Chemistry · doi:10.1373/49.10.1573 · Cited by 506
Mast, A. E., Blinder, M. A., Gronowski, A. M., Chumley, C., & Scott, M. G. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.1.45 · Cited by 481
Breast cancer trial with erythropoietin terminated unexpectedly
Leyland-Jones, B. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01163-x · Cited by 474
Locatelli, F., Pisoni, R. L., Combe, C., Bommer, J., Andreucci, V. E., Piera, L., Greenwood, R., Feldman, H. I., Port, F. K., & Held, P. J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg458 · Cited by 468
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., & Lin, H. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31342 · Cited by 457
Regulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222402 · Cited by 443
Pure Red-Cell Aplasia and Epoetin Therapy
Bennett, C. L., Luminari, S., Nissenson, A. R., Tallman, M. S., Klinge, S. A., McWilliams, N., McKoy, J. M., Kim, B., Lyons, E. A., Trifilio, S. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040528 · Cited by 437
The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
Sullivan, P. S., Hanson, D. L., Chu, S. Y., Jones, J. L., Ward, J. W., & Disease Group, T. A. S. O. (1998) · Blood · doi:10.1182/blood.v91.1.301 · Cited by 433
Body Iron Stores and the Risk of Cancer
Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 430
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Vamvakas, E. C., & Blajchman, M. A. (2001) · Blood · doi:10.1182/blood.v97.5.1180 · Cited by 423
Proinflammatory Cytokines Lowering Erythropoietin Production
JELKMANN, W. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.555 · Cited by 422
Cytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Rizzo, J. D., Lichtin, A. E., Woolf, S. H., Seidenfeld, J., Bennett, C. L., Cella, D., Djulbegovic, B., Goode, M. J., Jakubowski, A. A., Lee, S. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.177 · Cited by 417
Nicolle, L. S. (1984) · The Nurse Practitioner · doi:10.1097/00006205-198411000-00004 · Cited by 416
Auerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 414
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70008-x · Cited by 400
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Tonelli, M., Garg, A. X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00252 · Cited by 363
Anemia of inflammation: the cytokine-hepcidin link
Andrews, N. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21441 · Cited by 334
Iron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Self-citationHepcidin: from discovery to differential diagnosis
Kemna, E. H. J. M., Tjalsma, H., Willems, H. L., & Swinkels, D. W. (2008) · Haematologica · doi:10.3324/haematol.11705 · Cited by 313
Erythropoietin, iron, and erythropoiesis.
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · PubMed · Cited by 310
Self-citationRivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-04-1766 · Cited by 308
COLLINS, A. J., LI, S., PETER, W. S., EBBEN, J., ROBERTS, T., MA, J. Z., & MANNING, W. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112465 · Cited by 302
Erythropoietin, iron, and erythropoiesis
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · Blood · doi:10.1182/blood.v96.3.823 · Cited by 300
Self-citationRodriguez, R. M., Corwin, H. L., Gettinger, A., Corwin, M. J., Gubler, D., & Pearl, R. G. (2001) · Journal of Critical Care · doi:10.1053/jcrc.2001.21795 · Cited by 282
Pathogenesis and treatment of anaemia of chronic disease
Weiss, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0193 · Cited by 277
Erythropoietin, iron, and erythropoiesis
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · Blood · doi:10.1182/blood.v96.3.823.015k49_823_833 · Cited by 273
Self-citationHepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis
Vokurka, M., Krijt, J., Šulc, K., & Nečas, E. (2006) · Physiological Research · doi:10.33549/physiolres.930841 · Cited by 267
Glaser, C. M., Millesi, W., Kornek, G. V., Lang, S., Schüll, B., Watzinger, F., Selzer, E., & Lavey, R. S. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01488-2 · Cited by 263
Erythropoietin regulates tumour growth of human malignancies
Yasuda, Y. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg060 · Cited by 257
MORENO, F., SANZ-GUAJARDO, D., LÓPEZ-GÓMEZ, J. M., JOFRE, R., & VALDERRÁBANO, F. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v112335 · Cited by 254
Wilson, A., Reyes, E., & Ofman, J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.011 · Cited by 253
Sasu, B. J., Cooke, K. S., Arvedson, T. L., Plewa, C., Ellison, A. R., Sheng, J., Winters, A., Juan, T., Li, H., Begley, C. G., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245977 · Cited by 251
Andrews, N. C. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00065-5 · Cited by 248
Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease
van Rhee, F., Fayad, L., Voorhees, P., Furman, R., Lonial, S., Borghaei, H., Sokol, L., Crawford, J., Cornfeld, M., Qi, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2377 · Cited by 243
Iron, Free Radicals, and Oxidative Injury
McCord, J. M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3171s · Cited by 233
Beguin, Y., Clemons, G., Pootrakul, P., & Fillet, G. (1993) · Blood · doi:10.1182/blood.v81.4.1067.1067 · Cited by 227
Cachectin/tumor necrosis factor‐α alters red blood cell kinetics and induces anemia in vivo
Moldawer, L. L., Marano, M. A., Wei, H., Fong, Y., Silen, M. L., Kuo, G., Manogue, K. R., Vlassara, H., Cohen, H., Cerami, A., et al. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.5.2784116 · Cited by 226
Iron Loading and Disease Surveillance
Weinberg, E. D. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990305 · Cited by 225
Erythropoietin stimulates proliferation of human renal carcinoma cells
Westenfelder, C., & Baranowski, R. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00211.x · Cited by 222
Effect of hepcidin on intestinal iron absorption in mice
Laftah, A. H., Ramesh, B., Simpson, R. J., Solanky, N., Bahram, S., Schümann, K., Debnam, E. S., & Srai, S. K. S. (2004) · Blood · doi:10.1182/blood-2003-03-0953 · Cited by 217
Maciejewski, J. P., Selleri, C., Sato, T., Cho, H. J., Keefer, L. K., Nathan, C. F., & Young, N. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118094 · Cited by 209
Anemia: Not Just an Innocent Bystander?
Nissenson, A. R., Goodnough, L. T., & Dubois, R. W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1400 · Cited by 208
Self-citationCazzola, M., Ponchio, L., de Benedetti, F., Ravelli, A., Rosti, V, Beguin, Y., Invernizzi, R., Barosi, G., & Martini, A. (1996) · Blood · doi:10.1182/blood.v87.11.4824.bloodjournal87114824 · Cited by 197
Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia
Rivera, S., Liu, L., Nemeth, E., Gabayan, V., Sorensen, O. E., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2004-08-3375 · Cited by 196
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
Ludwig, H., Fritz, E., Leitgeb, C., Pecherstorfer, M., Samonigg, H., & Schuster, J. (1994) · Blood · doi:10.1182/blood.v84.4.1056.1056 · Cited by 196
Corradini, E., Meynard, D., Wu, Q., Chen, S., Ventura, P., Pietrangelo, A., & Babitt, J. L. (2011) · Hepatology · doi:10.1002/hep.24359 · Cited by 194
Acs, G., Zhang, P. J., McGrath, C. M., Acs, P., McBroom, J., Mohyeldin, A., Liu, S., Lu, H., & Verma, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64314-3 · Cited by 193
Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor.
Alvarez-Hernandez, X., Licéaga, J., McKay, I. C., & Brock, J. H. (1989) · PubMed · Cited by 192
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345066 · Cited by 189
Self-citationSun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y. (2012) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Lanzara, C. (2004) · Blood · doi:10.1182/blood-2004-01-0192 · Cited by 185
Recent developments in the anemia of chronic disease.
Means, R. T. (2003) · PubMed · Cited by 182
Role of IL-10 for induction of anemia during inflammation
Tilg, H., Ulmer, H., Kaser, A., & Weiss, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2204 · Cited by 181
Kroot, J. J. C., Kemna, E. H. J. M., Bansal, S. S., Busbridge, M., Campostrini, N., Girelli, D., Hider, R. C., Koliaraki, V., Mamalaki, A., Olbina, G., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010322 · Cited by 177
Functional Significance of Erythropoietin Receptor Expression in Breast Cancer
Arcasoy, M. O., Amin, K., Karayal, A. F., Chou, S.-C., Raleigh, J. A., Varia, M. A., & Haroon, Z. A. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000020415.72863.40 · Cited by 175
Lipocalins in drug discovery: From natural ligand-binding proteins to ‘anticalins’
Schlehuber, S., & Skerra, A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03294-5 · Cited by 171
The molecular basis of hepcidin-resistant hereditary hemochromatosis
Fernandes, A., Preza, G. C., Phung, Y., De Domenico, I., Kaplan, J., Ganz, T., & Nemeth, E. (2009) · Blood · doi:10.1182/blood-2008-03-146134 · Cited by 167
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
Mittelman, M., Neumann, D., Peled, A., Kanter, P., & Haran-Ghera, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081275298 · Cited by 158
Physiology of iron transport and the hemochromatosis gene
Pietrangelo, A. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00404.2001 · Cited by 154
Inhibition of iron transport across human intestinal epithelial cells by hepcidin
Yamaji, S., Sharp, P., Ramesh, B., & Srai, S. K. (2004) · Blood · doi:10.1182/blood-2004-03-0829 · Cited by 152
Means, R. T., & Krantz, S. B. (1991) · Blood · doi:10.1182/blood.v78.10.2564.2564 · Cited by 151
The role of inflammation in the anaemia of end-stage renal disease
Stenvinkel, P. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_7.36 · Cited by 150
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood · doi:10.1182/blood-2010-06-289082 · Cited by 148
Verga Falzacappa, M. V., Casanovas, G., Hentze, M. W., & Muckenthaler, M. U. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0313-7 · Cited by 146
Endothelial dysfunction and inflammation—is there a link?
Stenvinkel, P. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.10.1968 · Cited by 136
Kroot, J. J., Hendriks, J. C. M., Laarakkers, C. M., Klaver, S. M., Kemna, E., Tjalsma, H., & Swinkels, D. W. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.03.039 · Cited by 135
Cooper, A. C., Mikhail, A. I., Lethbridge, M. W., Kemeny, D. M., & Macdougall, I. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000071514.36428.61 · Cited by 134
Moura, E., Noordermeer, M. A., Verhoeven‐Duif, N. M., Verheul, A. F. M., & Marx, J. J. M. (1998) · Blood · doi:10.1182/blood.v92.7.2511 · Cited by 130
Roy, C. N., Custodio, Á. O., de Graaf, J., Schneider, S., Akpan, I. J., Montross, L. K., Sánchez, M., Gaudino, A., Hentze, M. W., Andrews, N. C., et al. (2004) · Nature Genetics · doi:10.1038/ng1350 · Cited by 128
Iron status and the outcome of HIV infection: an overview
Gordeuk, V. R., Delanghe, J. R., Langlois, M. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00134-7 · Cited by 124
Perlstein, T. S., Pande, R., Berliner, N., & Vanasse, G. J. (2011) · Blood · doi:10.1182/blood-2010-09-309708 · Cited by 122
Cella, D. F., Dobrez, D., & Glaspy, J. A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg167 · Cited by 113
Wang, C. Q., Udupa, K. B., & Lipschitz, D. A. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620116 · Cited by 107
Kaltwasser, J. P., Kessler, U., Gottschalk, R., Stucki, G., & Möller, B. (2001) · PubMed · Cited by 105
Weiss, G., Meusburger, E., Radacher, G., Garimorth, K., Neyer, U., & Mayer, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00099.x · Cited by 105
Teehan, G. S., Bahdouch, D., Ruthazer, R., Balakrishnan, V. S., Snydman, D. R., & Jaber, B. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382878 · Cited by 103
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia
Gasché, C., Waldhoer, T., Feichtenschlager, T., Male, C., Mayer, A., Mittermaier, C., & Petritsch, W. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04094.x · Cited by 101
Thompson, J. A., Gilliland, D. G., Prchal, J. T., Bennett, J. M., Larholt, K. M., Nelson, R. A., Rose, E. H., Dugan, M. H., & the GM/EPO MDS Study Group (2000) · Blood · doi:10.1182/blood.v95.4.1175.004k51_1175_1179 · Cited by 95
Iron and the anemia of chronic disease.
Spivak, J. L. (2002) · PubMed · Cited by 91
Toward third-generation aptamers: Spiegelmers and their therapeutic prospects.
Vater, A., & Klußmann, S. (2003) · PubMed · Cited by 91
Prevalence of anemia in cancer patients undergoing radiation therapy
Harrison, L. C., Shasha, D., Shiaova, L., White, C. B., Ramdeen, B., & Portenoy, R. K. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90214-3 · Cited by 88
Minoo, P., Zadeh, M. M., Rottapel, R., Lebrun, J., & Ali, S. (2004) · Blood · doi:10.1182/blood-2003-07-2617 · Cited by 87
Taniguchi, S., Dai, C.-H., Price, J. O., & Krantz, S. B. (1997) · Blood · doi:10.1182/blood.v90.6.2244 · Cited by 87
Inadequate erythropoietin response to anemia: definition and clinical relevance
Barosi, G. (1994) · Annals of Hematology · doi:10.1007/bf01737420 · Cited by 81
Post-liver-transplant anemia: Etiology and management
Maheshwari, A., Mishra, R., & Thuluvath, P. J. (2004) · Liver Transplantation · doi:10.1002/lt.20031 · Cited by 81
Dunn, A., Carter, J., & Carter, H. (2003) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.04.001 · Cited by 79
Erythropoietin for End-Stage Renal Disease
Adamson, J. W., & Eschbach, J. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390910 · Cited by 77
Anemia, Transfusion, and Mortality
Goodnough, L. T., & Bach, R. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200110253451711 · Cited by 71
Self-citationHashizume, M., Uchiyama, Y., Horai, N., Tomosugi, N., & Mihara, M. (2010) · Rheumatology International · doi:10.1007/s00296-009-1075-4 · Cited by 70
Feder, J. N. (1999) · Immunologic Research · doi:10.1007/bf02786472 · Cited by 67
Fatih, N., Camberlein, E., Island, M. L., Corlu, A., Abgueguen, E., Détivaud, L., Leroyer, P., Brissot, P., & Loréal, O. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0588-3 · Cited by 59
Hepatitis C virus outside the liver
Fox, R. K. (2003) · Current Hepatology Reports · doi:10.1007/s11901-003-0005-2 · Cited by 58
Erythropoietin and erythropoietin receptor.
Tilbrook, P. A., & Klinken, S. (1999) · Growth Factors · doi:10.3109/08977199909001060 · Cited by 58
Anemia Management in Chronic Kidney Disease: Role of Factors Affecting Epoetin Responsiveness
Eschbach, J. W. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016440.52271.f7 · Cited by 58
Henry, D., Abels, R., & Larholt, K. M. (1995) · Blood · doi:10.1182/blood.v85.6.1676.bloodjournal8561676 · Cited by 52
Yap, G. S., & Stevenson, M. M. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.357-362.1994 · Cited by 48
Denz, H. A., Huber, P., Landmann, R., Orth, B., WACHTER, H., & Fuchs, D. (1992) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1992.tb01801.x · Cited by 47
Maury, C. P. J., Liljeström, M., Laiho, K., Tiitinen, S., Kaarela, K., & Hurme, M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11294 · Cited by 39
Prevalence and Causes of Anemia in Elderly Hospitalized Patients
Matzner, Y., Lévy, S., Grossowicz, N., Izak, G., & Hershko, C. (2009) · Gerontology · doi:10.1159/000212328 · Cited by 38
Iron therapy and cardiovascular disease
Sullivan, J. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69135.x · Cited by 38
Hertel, J., Locay, H. R., Scarlata, D., Jackson, L., Prathikanti, R., & Audhya, P. (2006) · American Journal of Nephrology · doi:10.1159/000092852 · Cited by 38
High dose intravenous iron: a note of caution
Kletzmayr, J., Sunder-Plassmann, G., & Hörl, W. H. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.6.962 · Cited by 31
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
Salvarani, C., Baricchi, R., Lasagni, D., Boiardi, L., Piccinini, R., Brunati, C. C. M., Macchioni, P. L., & Portioli, I. (1996) · Rheumatology International · doi:10.1007/bf01816434 · Cited by 30
The impact of anemia correction on cardiovascular disease in end-stage renal disease.
Murphy, S. T., & Ps, P. (2000) · PubMed · Cited by 22
van Iperen, C. E., van de Wiel, A., & Marx, J. J. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03167.x · Cited by 19
Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients
Müller, H., Horina, J. H., Kniepeiss, D., Tripolt, M., Stadelbauer, V., Schweiger, M., & Tscheliessnigg, K. (2001) · Clinical Transplantation · doi:10.1034/j.1399-0012.2001.150507.x · Cited by 19
Gemcitabine/carboplatin combination regimens: importance of dose schedule.
Gandara, D. R., Lau, D. H., Lara, P. N., & Edelman, M. J. (2000) · PubMed · Cited by 19
Locatelli, F., Pisoni, R. L., Combe, C., Bommer, J., Andreucci, V. E., Piera, L., Greenwood, R. N., Feldman, H. I., FK, F. K. P., & Held, P. J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh314 · Cited by 18
Frost, A. E., & Keller, C. A. (1993) · PubMed · Cited by 16
Single and Repeated Dose First-in-Human Study with the Anti-Hepcidin Spiegelmer Nox-H94.
Riecke, K., Zöllner, S. K., Boyce, M. J., Vauléon, S., Swinkels, D. W., Dümmler, T., Summo, L., Laarakkers, C. M., Schwoebel, F., & Fliegert, F. (2012) · Blood · doi:10.1182/blood.v120.21.2342.2342 · Cited by 11
Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera, A., Bajo, M. A., Díez, J. J., Ruiz-Caravaca, M. L., Cuesta, M. V., Álvarez, V., Codoceo, R., & Selgas, R. (2002) · PubMed · Cited by 11
van Eijk, L. T., Swinkels, D. W., Aaron, J., Schwoebel, F., Fliegert, F., Summo, L., Stéphanie, V., Laarakkers, C. M., Riecke, K., & Pikkers, P. (2012) · Blood · doi:10.1182/blood.v120.21.3452.3452 · Cited by 7
Research works printed but not linked: 9
- Cartwright GE, 1966, Semin Hematol, 3, 351
- Frost AE, 1993, Transplantation, 56, 1008
- Alvarez-Hernandez X, 1989, Lab Invest, 61, 319
- Spivak JL, 2002, Oncology (Huntingt), 16, 25
- Murphy ST, 2000, Semin Nephrol, 20, 350
- Winn RJ, 2000, Oncology (Huntingt), 14, 26
- Kaltwasser JP, 2001, J Rheumatol, 28, 2430
- Aguilera A, 2002, Adv Perit Dial, 18, 200
- Acs G, 2001, Cancer Res, 61, 3561
Cited by
Dissecting racial bias in an algorithm used to manage the health of populations
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019) · Science · doi:10.1126/science.aax2342 · Cited by 7,137
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Advances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
“This points to the necessity of our understanding that exact speciation of iron in chronic anemias is linked to inflammatory diseases (Weiss and Goodnough, 2005).”
BackgroundNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Acute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103
Metadata
- Authors
- Weiss, G., & Goodnough, L. T.
- Affiliations
- Stanford Medicine (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-10
- Volume
- 352
- Issue
- 10
- Pages
- 1011-1023
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2123200029
- Cited by
- 3,800
- References
- 158
- Citations by year
- 2026: 121 · 2025: 159 · 2024: 136 · 2023: 136 · 2022: 169 · 2021: 179 · 2020: 184 · 2019: 179 · 2018: 204 · 2017: 206 · 2016: 174 · 2015: 222 · 2014: 229 · 2013: 185 · 2012: 208
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- anemia of chronic disease, iron homeostasis, erythroid progenitor cells, erythropoietin response, treatment options, anemia management
- MeSH terms
- Anemia, Animals, Blood Transfusion, Chronic Disease, Erythropoietin, Homeostasis, Humans, Iron, Erythroid Precursor Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.